This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chinese Academy of Medical Sciences, Guangdong Provincial Hospital of Tcm, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine. Active years: 2023.
Company Filing History:
1 out of 129 
1 out of 2 
1 out of 2 Years Active: 2023
Title: Hualun Liang: Innovator in Anti-Cancer Drug Development
Introduction
Hualun Liang is an esteemed inventor based in Guangdong, China, known for his significant contributions to the field of medical science. With a focus on innovative drug formulations, Liang has developed a promising new triptolide derivative aimed at combating cancer. His work reflects a commitment to advancing therapeutic options and improving patient outcomes.
Latest Patents
Liang holds a notable patent for "Triptolide acrylate, preparation method therefor and use thereof." This invention introduces a new triptolide derivative, which has shown remarkable anti-cancer activity after thorough in-vivo and in-vitro experiments. The compound not only effectively inhibits tumor growth but also promotes the apoptosis of tumor cells while exhibiting reduced toxicity to normal cells compared to traditional triptolide. The preparation method for this compound and its medical applications in developing anti-cancer drugs mark a significant advancement in cancer treatment.
Career Highlights
Throughout his career, Hualun Liang has worked at reputable medical institutions including the Guangdong Provincial Hospital of Traditional Chinese Medicine and The Second Affiliated Hospital of Guangzhou University of Chinese Medicine. His roles at these institutions have provided him the platform to research and develop effective therapeutic drugs aimed at tackling serious health challenges.
Collaborations
Liang has collaborated with esteemed colleagues in the medical field, including Bo Liu and Xianzhang Huang. These partnerships have fostered an environment of innovation and creativity, significantly contributing to his research endeavors and the successful development of his patented compounds.
Conclusion
Hualun Liang's contributions to cancer treatment through his innovative research and patent on triptolide acrylate highlight the importance of continuous innovation in the medical field. His dedication to improving therapeutic outcomes for patients suffering from cancer is commendable, and his ongoing work is likely to inspire further advancements in anti-cancer drug development.